{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:39:04Z","timestamp":1794274744430,"version":"4.9.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Federal Government | DHAC | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1182226"],"award-info":[{"award-number":["GNT1182226"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Federal Government | DHAC | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2025931"],"award-info":[{"award-number":["GNT2025931"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Federal Government | DHAC | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2003688"],"award-info":[{"award-number":["GNT2003688"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Department of Education and Training | Australian Research Council","doi-asserted-by":"publisher","award":["FT220100487"],"award-info":[{"award-number":["FT220100487"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Department of Education and Training | Australian Research Council","doi-asserted-by":"publisher","award":["FL180100109"],"award-info":[{"award-number":["FL180100109"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"published-print":{"date-parts":[[2025,5,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Toll-like receptor 4 (TLR4) signaling at the plasma membrane and in endosomes results in distinct contributions to inflammation and host defence. Current understanding indicates that endocytosis of cell surface-activated TLR4 is required to enable subsequent signaling from endosomes. Contrary to this prevailing model, our data show that endosomal TLR4 signaling is not reliant on cell surface-expressed TLR4 or ligand-induced TLR4 endocytosis. Moreover, previously recognized requirements for the accessory molecule CD14 in TLR4 endocytosis and endosomal signaling are likely attributable to CD14 binding as well as trafficking and transferring lipopolysaccharide (LPS) to TLR4 at different subcellular localizations. TLR4 endocytosis requires the TLR4 intracellular signaling domain, contributions by phospholipase C gamma 2, spleen tyrosine kinase, E1\/E2 ubiquitination enzymes, but not canonical TLR signaling adaptors and cascades. Thus, our study identifies independently operating TLR4 signaling modes that control TLR4 endocytosis, pro-inflammatory cell surface-derived, as well as endosomal TLR4 signaling. This revised understanding of how TLR4 functions within cells might be harnessed to selectively amplify or restrict TLR4 activation for the development of adjuvants, vaccines and therapeutics.<\/jats:p>","DOI":"10.1038\/s44319-025-00444-2","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T10:49:27Z","timestamp":1744195767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["TLR4 endocytosis and endosomal TLR4 signaling are distinct and independent outcomes of TLR4 activation"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2299-0557","authenticated-orcid":false,"given":"Thomas E","family":"Schultz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7406-2285","authenticated-orcid":false,"given":"Carmen D","family":"Mathmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6212-8785","authenticated-orcid":false,"given":"Leslie C","family":"Dom\u00ednguez Cadena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4384-5647","authenticated-orcid":false,"given":"Timothy W","family":"Muusse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3635-8234","authenticated-orcid":false,"given":"Hyoyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9638-8091","authenticated-orcid":false,"given":"Glen C","family":"Ulett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A","family":"Hamerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2691-1668","authenticated-orcid":false,"given":"Andrew J","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9413-9166","authenticated-orcid":false,"given":"Bostjan","family":"Kobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3992-7802","authenticated-orcid":false,"given":"Katryn J","family":"Stacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3673-7015","authenticated-orcid":false,"given":"Antje","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"444_CR1","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1002\/art.22848","volume":"56","author":"S Abdollahi-Roodsaz","year":"2007","unstructured":"Abdollahi-Roodsaz S, Joosten LA, Roelofs MF, Radstake TR, Matera G, Popa C, van der Meer JW, Netea MG, van den Berg WB (2007) Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum 56:2957\u20132967","journal-title":"Arthritis Rheum"},{"key":"444_CR2","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.2337\/db12-0677","volume":"62","author":"T Abe","year":"2013","unstructured":"Abe T, Hirasaka K, Kagawa S, Kohno S, Ochi A, Utsunomiya K, Sakai A, Ohno A, Teshima-Kondo S, Okumura Y et al (2013) Cbl-b is a critical regulator of macrophage activation associated with obesity-induced insulin resistance in mice. Diabetes 62:1957\u20131969","journal-title":"Diabetes"},{"key":"444_CR3","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1084\/jem.20031076","volume":"198","author":"S Akashi","year":"2003","unstructured":"Akashi S, Saitoh S-i, Wakabayashi Y, Kikuchi T, Takamura N, Nagai Y, Kusumoto Y, Fukase K, Kusumoto S, Adachi Y et al (2003) Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14. J Exp Med 198:1035\u20131042","journal-title":"J Exp Med"},{"key":"444_CR4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.immuni.2016.07.010","volume":"45","author":"MA Akbar","year":"2016","unstructured":"Akbar MA, Mandraju R, Tracy C, Hu W, Pasare C, Kr\u00e4mer H (2016) ARC syndrome-linked Vps33B protein is required for inflammatory endosomal maturation and signal termination. Immunity 45:267\u2013279","journal-title":"Immunity"},{"key":"444_CR5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783\u2013801","journal-title":"Cell"},{"key":"444_CR6","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni.2426","volume":"13","author":"E Aksoy","year":"2012","unstructured":"Aksoy E, Taboubi S, Torres D, Delbauve S, Hachani A, Whitehead MA, Pearce WP, Berenjeno IM, Nock G, Filloux A et al (2012) The p110\u03b4 isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock. Nat Immunol 13:1045","journal-title":"Nat Immunol"},{"key":"444_CR7","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/med.21553","volume":"39","author":"MA Anwar","year":"2019","unstructured":"Anwar MA, Shah M, Kim J, Choi S (2019) Recent clinical trends in Toll-like Receptor targeting therapeutics. Med Res Rev 39:1053\u20131090","journal-title":"Med Res Rev"},{"key":"444_CR8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/bbrc.2001.5536","volume":"287","author":"M Awasthi-Kalia","year":"2001","unstructured":"Awasthi-Kalia M, Schnetkamp PPM, Deans JP (2001) Differential effects of filipin and methyl-\u03b2-cyclodextrin on B cell receptor signaling. Biochem Biophys Res Comm 287:77\u201382","journal-title":"Biochem Biophys Res Comm"},{"key":"444_CR9","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/nm1607","volume":"13","author":"K Bachmaier","year":"2007","unstructured":"Bachmaier K, Toya S, Gao X, Triantafillou T, Garrean S, Park GY, Frey RS, Vogel S, Minshall R, Christman JW et al (2007) E3 ubiquitin ligase Cblb regulates the acute inflammatory response underlying lung injury. Nat Med 13:920\u2013926","journal-title":"Nat Med"},{"key":"444_CR10","first-page":"81","volume":"270","author":"GM Barton","year":"2002","unstructured":"Barton GM, Medzhitov R (2002) Toll-like receptors and their ligands. Curr Top Microbiol Immunol 270:81\u201392","journal-title":"Curr Top Microbiol Immunol"},{"key":"444_CR11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.str.2011.02.004","volume":"19","author":"I Botos","year":"2011","unstructured":"Botos I, Segal DM, Davies DR (2011) The structural biology of Toll-like receptors. Structure 19:447\u2013459","journal-title":"Structure"},{"key":"444_CR12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/blood.2019002561","volume":"135","author":"JL Bridgford","year":"2020","unstructured":"Bridgford JL, Lee SM, Lee CMM, Guglielmelli P, Rumi E, Pietra D, Wilcox S, Chhabra Y, Rubin AF, Cazzola M et al (2020) Novel drivers and modifiers of MPL-dependent oncogenic transformation identified by deep mutational scanning. Blood 135:287\u2013292","journal-title":"Blood"},{"key":"444_CR13","doi-asserted-by":"crossref","first-page":"12879","DOI":"10.1073\/pnas.0603038103","volume":"103","author":"E Brzuszkiewicz","year":"2006","unstructured":"Brzuszkiewicz E, Br\u00fcggemann H, Liesegang H, Emmerth M, \u00d6lschl\u00e4ger T, Nagy G, Albermann K, Wagner C, Buchrieser C, Em\u0151dy L et al (2006) How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc Natl Acad Sci USA 103:12879\u201312884","journal-title":"Proc Natl Acad Sci USA"},{"key":"444_CR14","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.cell.2020.02.019","volume":"180","author":"HY Chew","year":"2020","unstructured":"Chew HY, De Lima PO, Gonzalez Cruz JL, Banushi B, Echejoh G, Hu L, Joseph SR, Lum B, Rae J, O\u2019Donnell JS et al (2020) Endocytosis inhibition in humans to improve responses to ADCC-mediating antibodies. Cell 180:895\u2013914.e827","journal-title":"Cell"},{"key":"444_CR15","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1074\/jbc.C111.328559","volume":"287","author":"CY Chiang","year":"2012","unstructured":"Chiang CY, Veckman V, Limmer K, David M (2012) Phospholipase C\u03b3-2 and intracellular calcium are required for lipopolysaccharide-induced Toll-like Receptor 4 (TLR4) endocytosis and interferon regulatory factor 3 (IRF3) activation. J Biol Chem 287:3704\u20133709","journal-title":"J Biol Chem"},{"key":"444_CR16","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","volume":"78","author":"A Ciesielska","year":"2021","unstructured":"Ciesielska A, Matyjek M, Kwiatkowska K (2021) TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci 78:1233\u20131261","journal-title":"Cell Mol Life Sci"},{"key":"444_CR17","volume":"53","author":"JEB Curson","year":"2023","unstructured":"Curson JEB, Liu L, Luo L, Muusse TW, Lucas RM, Gunther KS, Vajjhala PR, Abrol R, Jones A, Kapetanovic R et al (2023) TLR4 phosphorylation at tyrosine 672 activates the ERK\/c-FOS signaling module for LPS-induced cytokine responses in macrophages. Eur J Immunol 53:2250056","journal-title":"Eur J Immunol"},{"key":"444_CR18","doi-asserted-by":"crossref","first-page":"36560","DOI":"10.1074\/jbc.M506831200","volume":"280","author":"N Cusson-Hermance","year":"2005","unstructured":"Cusson-Hermance N, Khurana S, Lee TH, Fitzgerald KA, Kelliher MA (2005) RIP1 mediates the TRIF-dependent Toll-like Receptor 3- and 4-induced NF-\u03baB activation but does not contribute to interferon regulatory factor 3 activation. J Biol Chem 280:36560\u201336566","journal-title":"J Biol Chem"},{"key":"444_CR19","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1074\/jbc.M109910200","volume":"277","author":"J da Silva Correia","year":"2002","unstructured":"da Silva Correia J, Ulevitch RJ (2002) MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. J Bio Chem 277:1845\u20131854","journal-title":"J Bio Chem"},{"key":"444_CR20","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.4049\/jimmunol.1300496","volume":"190","author":"M Deng","year":"2013","unstructured":"Deng M, Scott MJ, Loughran P, Gibson G, Sodhi C, Watkins S, Hackam D, Billiar TR (2013) Lipopolysaccharide clearance, bacterial clearance, and systemic inflammatory responses are regulated by cell type-specific functions of TLR4 during sepsis. J Immunol 190:5152\u20135160","journal-title":"J Immunol"},{"key":"444_CR21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1165\/ajrcmb.19.2.3149","volume":"19","author":"MA Fiedler","year":"1998","unstructured":"Fiedler MA, Wernke-Dollries K, Stark JM (1998) Inhibition of TNF-\u03b1-induced NF-\u03baB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132. Am J Respir Cell Mol Biol 19:259\u2013268","journal-title":"Am J Respir Cell Mol Biol"},{"key":"444_CR22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-024-07614-7","volume":"631","author":"D Fisch","year":"2024","unstructured":"Fisch D, Zhang T, Sun H, Ma W, Tan Y, Gygi SP, Higgins DE, Kagan JC (2024) Molecular definition of the endogenous Toll-like receptor signalling pathways. Nature 631:635\u2013644","journal-title":"Nature"},{"key":"444_CR23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/35092578","volume":"413","author":"KA Fitzgerald","year":"2001","unstructured":"Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, Brint E, Dunne A, Gray P, Harte MT et al (2001) Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413:78\u201383","journal-title":"Nature"},{"key":"444_CR24","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1084\/jem.176.6.1665","volume":"176","author":"EA Frey","year":"1992","unstructured":"Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevik T, Finlay BB, Wright SD (1992) Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 176:1665\u20131671","journal-title":"J Exp Med"},{"key":"444_CR25","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1152\/ajpgi.00098.2016","volume":"311","author":"M Guerville","year":"2016","unstructured":"Guerville M, Boudry G (2016) Gastrointestinal and hepatic mechanisms limiting entry and dissemination of lipopolysaccharide into the systemic circulation. Am J Physiol Gastrointest Liver Physiol 311:G1\u2013G15","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"444_CR26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1242\/jcs.091280","volume":"125","author":"K Haglund","year":"2012","unstructured":"Haglund K, Dikic I (2012) The role of ubiquitylation in receptor endocytosis and endosomal sorting. J Cell Sci 125:265","journal-title":"J Cell Sci"},{"key":"444_CR27","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51700","volume":"8","author":"N Hajicek","year":"2019","unstructured":"Hajicek N, Keith NC, Siraliev-Perez E, Temple BRS, Huang W, Zhang Q, Harden TK, Sondek J (2019) Structural basis for the activation of PLC-\u03b3 isozymes by phosphorylation and cancer-associated mutations. eLife 8:e51700","journal-title":"eLife"},{"key":"444_CR28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1124\/jpet.114.214312","volume":"350","author":"T Hayashi","year":"2014","unstructured":"Hayashi T, Crain B, Yao S, Caneda CD, Cottam HB, Chan M, Corr M, Carson DA (2014) Novel synthetic Toll-like receptor 4\/MD2 ligands attenuate sterile inflammation. J Pharm Exp Ther 350:330\u2013340","journal-title":"J Pharm Exp Ther"},{"key":"444_CR29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/ph16010023","volume":"16","author":"H Heine","year":"2023","unstructured":"Heine H, Zamyatina A (2023) Therapeutic targeting of TLR4 for inflammation, infection, and cancer: a perspective for disaccharide lipid A mimetics. Pharmaceuticals 16:23","journal-title":"Pharmaceuticals"},{"key":"444_CR30","doi-asserted-by":"crossref","first-page":"e43580","DOI":"10.1371\/journal.pone.0043580","volume":"7","author":"SB Hermanson","year":"2012","unstructured":"Hermanson SB, Carlson CB, Riddle SM, Zhao J, Vogel KW, Nichols RJ, Bi K (2012) Screening for novel LRRK2 inhibitors using a high-throughput TR-FRET cellular assay for LRRK2 Ser935 phosphorylation. PLoS ONE 7:e43580","journal-title":"PLoS ONE"},{"key":"444_CR31","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nature01889","volume":"424","author":"K Hoebe","year":"2003","unstructured":"Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, Goode J, Lin P, Mann N, Mudd S et al (2003) Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424:743\u2013748","journal-title":"Nature"},{"key":"444_CR32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejphar.2017.07.012","volume":"812","author":"MC Hsu","year":"2017","unstructured":"Hsu MC, Liu SH, Wang CW, Hu NY, Wu ESC, Shih YC, Chiu PJS (2017) JKB-122 is effective, alone or in combination with prednisolone in Con A-induced hepatitis. Eur J Pharm 812:113\u2013120","journal-title":"Eur J Pharm"},{"key":"444_CR33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/cr.2016.40","volume":"26","author":"H Hu","year":"2016","unstructured":"Hu H, Sun SC (2016) Ubiquitin signaling in immune responses. Cell Res 26:457\u2013483","journal-title":"Cell Res"},{"key":"444_CR34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.immuni.2010.09.010","volume":"33","author":"H Husebye","year":"2010","unstructured":"Husebye H, Aune MH, Stenvik J, Samstad E, Skjeldal F, Halaas O, Nilsen NJ, Stenmark H, Latz E, Lien E et al (2010) The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes. Immunity 33:583\u2013596","journal-title":"Immunity"},{"key":"444_CR35","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.emboj.7600991","volume":"25","author":"H Husebye","year":"2006","unstructured":"Husebye H, Halaas \u00d8, Stenmark H, Tunheim G, Sandanger \u00d8, Bogen B, Brech A, Latz E, Espevik T (2006) Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J 25:683\u2013692","journal-title":"EMBO J"},{"key":"444_CR36","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nm.4474","volume":"24","author":"ML Hyer","year":"2018","unstructured":"Hyer ML, Milhollen MA, Ciavarri J, Fleming P, Traore T, Sappal D, Huck J, Shi J, Gavin J, Brownell J et al (2018) A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment. Nat Med 24:186\u2013193","journal-title":"Nat Med"},{"key":"444_CR37","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1002\/eji.200636038","volume":"36","author":"B Jacque","year":"2006","unstructured":"Jacque B, Stephan K, Smirnova I, Kim B, Gilling D, Poltorak A (2006) Mice expressing high levels of soluble CD14 retain LPS in the circulation and are resistant to LPS-induced lethality. Eur J Immunol 36:3007\u20133016","journal-title":"Eur J Immunol"},{"key":"444_CR38","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/ni1207","volume":"6","author":"Z Jiang","year":"2005","unstructured":"Jiang Z, Georgel P, Du X, Shamel L, Sovath S, Mudd S, Huber M, Kalis C, Keck S, Galanos C et al (2005) CD14 is required for MyD88-independent LPS signaling. Nat Immunol 6:565\u2013570","journal-title":"Nat Immunol"},{"key":"444_CR39","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.cell.2006.03.047","volume":"125","author":"JC Kagan","year":"2006","unstructured":"Kagan JC, Medzhitov R (2006) Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125:943\u2013955","journal-title":"Cell"},{"key":"444_CR40","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/ni1569","volume":"9","author":"JC Kagan","year":"2008","unstructured":"Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R (2008) TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 9:361\u2013368","journal-title":"Nat Immunol"},{"key":"444_CR41","doi-asserted-by":"crossref","first-page":"a000166","DOI":"10.1101\/cshperspect.a000166","volume":"2","author":"N Kanarek","year":"2010","unstructured":"Kanarek N, London N, Schueler-Furman O, Ben-Neriah Y (2010) Ubiquitination and degradation of the inhibitors of NF-\u03baB. Cold Spring Harb Perspect Biol 2:a000166","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"444_CR42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1074-7613(00)80086-2","volume":"11","author":"T Kawai","year":"1999","unstructured":"Kawai T, Adachi O, Ogawa T, Takeda K, Akira S (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:115\u2013122","journal-title":"Immunity"},{"key":"444_CR43","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","volume":"57","author":"T Kawai","year":"2024","unstructured":"Kawai T, Ikegawa M, Ori D, Akira S (2024) Decoding Toll-like receptors: recent insights and perspectives in innate immunity. Immunity 57:649\u2013673","journal-title":"Immunity"},{"key":"444_CR44","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cyto.2008.07.010","volume":"43","author":"EF Kenny","year":"2008","unstructured":"Kenny EF, O\u2019Neill LA (2008) Signalling adaptors used by Toll-like receptors: an update. Cytokine 43:342\u2013349","journal-title":"Cytokine"},{"key":"444_CR45","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.4049\/jimmunol.160.4.1920","volume":"160","author":"RL Kitchens","year":"1998","unstructured":"Kitchens RL, Munford RS (1998) CD14-dependent internalization of bacterial lipopolysaccharide (LPS) is strongly influenced by LPS aggregation but not by cellular responses to LPS. J Immunol 160:1920","journal-title":"J Immunol"},{"key":"444_CR46","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.4049\/jimmunol.161.10.5534","volume":"161","author":"RL Kitchens","year":"1998","unstructured":"Kitchens RL, Wang P-y, Munford RS (1998) Bacterial lipopolysaccharide can enter monocytes via two CD14-dependent pathways. J Immunol 161:5534","journal-title":"J Immunol"},{"key":"444_CR47","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.4049\/jimmunol.176.10.6211","volume":"176","author":"M Kobayashi","year":"2006","unstructured":"Kobayashi M, Saitoh S, Tanimura N, Takahashi K, Kawasaki K, Nishijima M, Fujimoto Y, Fukase K, Akashi-Takamura S, Miyake K (2006) Regulatory roles for MD-2 and TLR4 in ligand-induced receptor clustering. J Immunol 176:6211\u20136218","journal-title":"J Immunol"},{"key":"444_CR48","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1083\/jcb.200908086","volume":"188","author":"M Koivusalo","year":"2010","unstructured":"Koivusalo M, Welch C, Hayashi H, Scott CC, Kim M, Alexander T, Touret N, Hahn KM, Grinstein S (2010) Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J Cell Biol 188:547\u2013563","journal-title":"J Cell Biol"},{"key":"444_CR49","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/s41556-023-01269-8","volume":"25","author":"P Kumari","year":"2023","unstructured":"Kumari P, Vasudevan SO, Russo AJ, Wright SS, Fraile-\u00c1greda V, Krajewski D, Jellison ER, Rubio I, Bauer M, Shimoyama A et al (2023) Host extracellular vesicles confer cytosolic access to systemic LPS licensing non-canonical inflammasome sensing and pyroptosis. Nat Cell Biol 25:1860\u20131872","journal-title":"Nat Cell Biol"},{"key":"444_CR50","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1021\/acs.jmedchem.0c01491","volume":"64","author":"SP Langston","year":"2021","unstructured":"Langston SP, Grossman S, England D, Afroze R, Bence N, Bowman D, Bump N, Chau R, Chuang BC, Claiborne C et al (2021) Discovery of TAK-981, a first-in-class inhibitor of SUMO-activating enzyme for the treatment of cancer. J Med Chem 64:2501\u20132520","journal-title":"J Med Chem"},{"key":"444_CR51","doi-asserted-by":"crossref","first-page":"e31377","DOI":"10.7554\/eLife.31377","volume":"7","author":"SL Latty","year":"2018","unstructured":"Latty SL, Sakai J, Hopkins L, Verstak B, Paramo T, Berglund NA, Cammarota E, Cicuta P, Gay NJ, Bond PJ et al (2018) Activation of Toll-like Receptors nucleates assembly of the MyDDosome signaling hub. eLife 7:e31377","journal-title":"eLife"},{"key":"444_CR52","doi-asserted-by":"crossref","first-page":"47834","DOI":"10.1074\/jbc.M207873200","volume":"277","author":"E Latz","year":"2002","unstructured":"Latz E, Visintin A, Lien E, Fitzgerald KA, Monks BG, Kurt-Jones EA, Golenbock DT, Espevik T (2002) Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem 277:47834\u201347843","journal-title":"J Biol Chem"},{"key":"444_CR53","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.4049\/jimmunol.181.2.1446","volume":"181","author":"KL Lloyd-Jones","year":"2008","unstructured":"Lloyd-Jones KL, Kelly MM, Kubes P (2008) Varying importance of soluble and membrane CD14 in endothelial detection of lipopolysaccharide. J Immunol 181:1446\u20131453","journal-title":"J Immunol"},{"key":"444_CR54","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4049\/jimmunol.151.2.959","volume":"151","author":"M Luchi","year":"1993","unstructured":"Luchi M, Munford RS (1993) Binding, internalization, and deacylation of bacterial lipopolysaccharide by human neutrophils. J Immunol 151:959\u2013969","journal-title":"J Immunol"},{"key":"444_CR55","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.devcel.2006.04.002","volume":"10","author":"E Macia","year":"2006","unstructured":"Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T (2006) Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10:839\u2013850","journal-title":"Dev Cell"},{"key":"444_CR56","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2010.12.007","volume":"33","author":"BA Malynn","year":"2010","unstructured":"Malynn BA, Ma A (2010) Ubiquitin makes its mark on immune regulation. Immunity 33:843\u2013852","journal-title":"Immunity"},{"key":"444_CR57","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/mol.110.068064","volume":"79","author":"N Matsunaga","year":"2011","unstructured":"Matsunaga N, Tsuchimori N, Matsumoto T, Ii M (2011) TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules. Mol Pharm 79:34\u201341","journal-title":"Mol Pharm"},{"key":"444_CR58","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.biocel.2013.05.026","volume":"45","author":"GS McDowell","year":"2013","unstructured":"McDowell GS, Philpott A (2013) Non-canonical ubiquitylation: mechanisms and consequences. Int J Biochem Cell Biol 45:1833\u20131842","journal-title":"Int J Biochem Cell Biol"},{"key":"444_CR59","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1042\/BST20220880","volume":"51","author":"AJ Middleton","year":"2023","unstructured":"Middleton AJ, Day CL (2023) From seeds to trees: how E2 enzymes grow ubiquitin chains. Biochem Soc Trans 51:353\u2013362","journal-title":"Biochem Soc Trans"},{"key":"444_CR60","doi-asserted-by":"crossref","first-page":"25404","DOI":"10.1074\/jbc.M109.022392","volume":"284","author":"PG Motshwene","year":"2009","unstructured":"Motshwene PG, Moncrieffe MC, Grossmann JG, Kao C, Ayaluru M, Sandercock AM, Robinson CV, Latz E, Gay NJ (2009) An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4*. J Biol Chem 284:25404\u201325411","journal-title":"J Biol Chem"},{"key":"444_CR61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1086\/649558","volume":"201","author":"RS Munford","year":"2010","unstructured":"Munford RS (2010) Murine responses to endotoxin: another dirty little secret? J Infect Dis 201:175\u2013177","journal-title":"J Infect Dis"},{"key":"444_CR62","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025343118","volume":"118","author":"J Myeong","year":"2021","unstructured":"Myeong J, Park C-G, Suh B-C, Hille B (2021) Compartmentalization of phosphatidylinositol 4,5-bisphosphate metabolism into plasma membrane liquid-ordered\/raft domains. Proc Natl Acad Sci USA 118:e2025343118","journal-title":"Proc Natl Acad Sci USA"},{"key":"444_CR63","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1182\/blood.2021014267","volume":"139","author":"A Nakamura","year":"2022","unstructured":"Nakamura A, Grossman S, Song K, Xega K, Zhang Y, Cvet D, Berger A, Shapiro G, Huszar D (2022) The SUMOylation inhibitor subasumstat potentiates rituximab activity by IFN1-dependent macrophage and NK cell stimulation. Blood 139:2770\u20132781","journal-title":"Blood"},{"key":"444_CR64","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1073\/pnas.1111957108","volume":"109","author":"M Ni","year":"2012","unstructured":"Ni M, MacFarlane AWT, Toft M, Lowell CA, Campbell KS, Hamerman JA (2012) B-cell adaptor for PI3K (BCAP) negatively regulates Toll-like receptor signaling through activation of PI3K. Proc Natl Acad Sci USA 109:267\u2013272","journal-title":"Proc Natl Acad Sci USA"},{"key":"444_CR65","doi-asserted-by":"crossref","first-page":"e788","DOI":"10.1371\/journal.pone.0000788","volume":"2","author":"R N\u00fa\u00f1ez Miguel","year":"2007","unstructured":"N\u00fa\u00f1ez Miguel R, Wong J, Westoll JF, Brooks HJ, O\u2019Neill LA, Gay NJ, Bryant CE, Monie TP (2007) A dimer of the Toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins. PLoS ONE 2:e788","journal-title":"PLoS ONE"},{"key":"444_CR66","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jama.2013.2194","volume":"309","author":"SM Opal","year":"2013","unstructured":"Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, Wittebole X, Dugernier T, Perrotin D, Tidswell M et al (2013) Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA 309:1154\u20131162","journal-title":"JAMA"},{"key":"444_CR67","first-page":"5305","volume":"126","author":"RJ Park","year":"2013","unstructured":"Park RJ, Shen H, Liu L, Liu X, Ferguson SM, De Camilli P (2013) Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors. J Cell Sci 126:5305\u20135312","journal-title":"J Cell Sci"},{"key":"444_CR68","doi-asserted-by":"crossref","first-page":"11376","DOI":"10.1074\/jbc.C114.627778","volume":"290","author":"KJ Petherick","year":"2015","unstructured":"Petherick KJ, Conway OJ, Mpamhanga C, Osborne SA, Kamal A, Saxty B, Ganley IG (2015) Pharmacological inhibition of ULK1 kinase blocks mammalian target of rapamycin (mTOR)-dependent autophagy. J Biol Chem 290:11376\u201311383","journal-title":"J Biol Chem"},{"key":"444_CR69","doi-asserted-by":"crossref","first-page":"e1003834","DOI":"10.1371\/journal.pgen.1003834","volume":"9","author":"MD Phan","year":"2013","unstructured":"Phan MD, Peters KM, Sarkar S, Lukowski SW, Allsopp LP, Gomes Moriel D, Achard ME, Totsika M, Marshall VM, Upton M et al (2013) The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone. PLoS Genet 9:e1003834","journal-title":"PLoS Genet"},{"key":"444_CR70","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","volume":"282","author":"A Poltorak","year":"1998","unstructured":"Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C et al (1998) Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene. Science 282:2085\u20132088","journal-title":"Science"},{"key":"444_CR71","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1096\/fj.14-265207","volume":"29","author":"G Preta","year":"2015","unstructured":"Preta G, Lotti V, Cronin JG, Sheldon IM (2015) Protective role of the dynamin inhibitor Dynasore against the cholesterol-dependent cytolysin of Trueperella pyogenes. FASEB J 29:1516\u20131528","journal-title":"FASEB J"},{"key":"444_CR72","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1182\/blood-2012-02-406074","volume":"120","author":"M Pulvino","year":"2012","unstructured":"Pulvino M, Liang Y, Oleksyn D, DeRan M, Van Pelt E, Shapiro J, Sanz I, Chen L, Zhao J (2012) Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A. Blood 120:1668\u20131677","journal-title":"Blood"},{"key":"444_CR73","doi-asserted-by":"crossref","first-page":"8391","DOI":"10.1073\/pnas.1424980112","volume":"112","author":"R Rajaiah","year":"2015","unstructured":"Rajaiah R, Perkins DJ, Ireland DD, Vogel SN (2015) CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance. Proc Natl Acad Sci USA 112:8391\u20138396","journal-title":"Proc Natl Acad Sci USA"},{"key":"444_CR74","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/ismej.2013.238","volume":"8","author":"O Rendueles","year":"2014","unstructured":"Rendueles O, Beloin C, Latour-Lambert P, Ghigo J-M (2014) A new biofilm-associated colicin with increased efficiency against biofilm bacteria. ISME J 8:1275\u20131288","journal-title":"ISME J"},{"key":"444_CR75","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41565-021-00858-8","volume":"16","author":"JJ Rennick","year":"2021","unstructured":"Rennick JJ, Johnston APR, Parton RG (2021) Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics. Nat Nanotech 16:266\u2013276","journal-title":"Nat Nanotech"},{"key":"444_CR76","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/CCM.0b013e3181e7c5c9","volume":"38","author":"TW Rice","year":"2010","unstructured":"Rice TW, Wheeler AP, Bernard GR, Vincent JL, Angus DC, Aikawa N, Demeyer I, Sainati S, Amlot N, Cao C et al (2010) A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med 38:1685\u20131694","journal-title":"Crit Care Med"},{"key":"444_CR77","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1432-1327.2000.00956.x","volume":"267","author":"S Saito","year":"2000","unstructured":"Saito S, Matsuura M, Tominaga K, Kirikae T, Nakano M (2000) Important role of membrane-associated CD14 in the induction of IFN-beta and subsequent nitric oxide production by murine macrophages in response to bacterial lipopolysaccharide. Eur J Biochem 267:37\u201345","journal-title":"Eur J Biochem"},{"key":"444_CR78","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.4049\/jimmunol.171.8.4304","volume":"171","author":"S Sato","year":"2003","unstructured":"Sato S, Sugiyama M, Yamamoto M, Watanabe Y, Kawai T, Takeda K, Akira S (2003) Toll\/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling. J Immunol 171:4304\u20134310","journal-title":"J Immunol"},{"key":"444_CR79","doi-asserted-by":"crossref","first-page":"e2926","DOI":"10.21769\/BioProtoc.2926","volume":"8","author":"MS Schappe","year":"2018","unstructured":"Schappe MS, Desai BN (2018) Measurement of TLR4 and CD14 receptor endocytosis using flow cytometry. Bio Protoc 8:e2926","journal-title":"Bio Protoc"},{"key":"444_CR80","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.immuni.2017.11.026","volume":"48","author":"MS Schappe","year":"2018","unstructured":"Schappe MS, Szteyn K, Stremska ME, Mendu SK, Downs TK, Seegren PV, Mahoney MA, Dixit S, Krupa JK, Stipes EJ et al (2018) Chanzyme TRPM7 mediates the Ca2+ influx essential for lipopolysaccharide-induced Toll-like receptor 4 endocytosis and macrophage activation. Immunity 48:59\u201374.e55","journal-title":"Immunity"},{"key":"444_CR81","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1753425919846281","volume":"26","author":"KA Shirey","year":"2020","unstructured":"Shirey KA, Lai W, Brown LJ, Blanco JCG, Beadenkopf R, Wang Y, Vogel SN, Snyder GA (2020) Select targeting of intracellular Toll-interleukin-1 receptor resistance domains for protection against influenza-induced disease. Innate Immun 26:26\u201334","journal-title":"Innate Immun"},{"key":"444_CR82","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature12118","volume":"497","author":"KA Shirey","year":"2013","unstructured":"Shirey KA, Lai W, Scott AJ, Lipsky M, Mistry P, Pletneva LM, Karp CL, McAlees J, Gioannini TL, Weiss J (2013) The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature 497:498\u2013502","journal-title":"Nature"},{"key":"444_CR83","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrm2748","volume":"10","author":"A Sorkin","year":"2009","unstructured":"Sorkin A, von Zastrow M (2009) Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol 10:609\u2013622","journal-title":"Nat Rev Mol Cell Biol"},{"key":"444_CR84","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nature07884","volume":"458","author":"TA Soucy","year":"2009","unstructured":"Soucy TA, Smith PG, Milhollen MA, Berger AJ, Gavin JM, Adhikari S, Brownell JE, Burke KE, Cardin DP, Critchley S et al (2009) An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 458:732\u2013736","journal-title":"Nature"},{"key":"444_CR85","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1042\/BJ20121651","volume":"451","author":"S Strickson","year":"2013","unstructured":"Strickson S, Campbell DG, Emmerich CH, Knebel A, Plater L, Ritorto MS, Shpiro N, Cohen P (2013) The anti-inflammatory drug BAY 11-7082 suppresses the MyD88-dependent signalling network by targeting the ubiquitin system. Biochem J 451:427\u2013437","journal-title":"Biochem J"},{"key":"444_CR86","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1084\/jem.20071132","volume":"204","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Shibata T, Akashi-Takamura S, Kiyokawa T, Wakabayashi Y, Tanimura N, Kobayashi T, Matsumoto F, Fukui R, Kouro T et al (2007) A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses. J Exp Med 204:2963\u20132976","journal-title":"J Exp Med"},{"key":"444_CR87","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1476-5381.2009.00297.x","volume":"157","author":"K Takashima","year":"2009","unstructured":"Takashima K, Matsunaga N, Yoshimatsu M, Hazeki K, Kaisho T, Uekata M, Hazeki O, Akira S, Iizawa Y, Ii M (2009) Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model. Br J Pharm 157:1250\u20131262","journal-title":"Br J Pharm"},{"key":"444_CR88","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140:805\u2013820","journal-title":"Cell"},{"key":"444_CR89","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/tra.12454","volume":"18","author":"Y Tan","year":"2017","unstructured":"Tan Y, Kagan JC (2017) Microbe-inducible trafficking pathways that control Toll-like receptor signaling. Traffic 18:6\u201317","journal-title":"Traffic"},{"key":"444_CR90","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.immuni.2015.10.008","volume":"43","author":"Y Tan","year":"2015","unstructured":"Tan Y, Zanoni I, Cullen Thomas W, Goodman Andrew L, Kagan Jonathan C (2015) Mechanisms of Toll-like receptor 4 endocytosis reveal a common immune-evasion strategy used by pathogenic and commensal bacteria. Immunity 43:909\u2013922","journal-title":"Immunity"},{"key":"444_CR91","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbrc.2008.01.061","volume":"368","author":"N Tanimura","year":"2008","unstructured":"Tanimura N, Saitoh S, Matsumoto F, Akashi-Takamura S, Miyake K (2008) Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling. Biochem Biophys Res Comm 368:94\u201399","journal-title":"Biochem Biophys Res Comm"},{"key":"444_CR92","doi-asserted-by":"crossref","first-page":"23157","DOI":"10.1074\/jbc.272.37.23157","volume":"272","author":"RI Tapping","year":"1997","unstructured":"Tapping RI, Tobias PS (1997) Cellular binding of soluble CD14 requires lipopolysaccharide (LPS) and LPS-binding protein*. J Biol Chem 272:23157\u201323164","journal-title":"J Biol Chem"},{"key":"444_CR93","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/86342","volume":"2","author":"K Triantafilou","year":"2001","unstructured":"Triantafilou K, Triantafilou M, Dedrick RL (2001) A CD14-independent LPS receptor cluster. Nat Immunol 2:338\u2013345","journal-title":"Nat Immunol"},{"key":"444_CR94","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1242\/jcs.115.12.2603","volume":"115","author":"M Triantafilou","year":"2002","unstructured":"Triantafilou M, Miyake K, Golenbock DT, Triantafilou K (2002) Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci 115:2603\u20132611","journal-title":"J Cell Sci"},{"key":"444_CR95","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1073\/pnas.1118579109","volume":"109","author":"TD Troutman","year":"2012","unstructured":"Troutman TD, Hu W, Fulenchek S, Yamazaki T, Kurosaki T, Bazan JF, Pasare C (2012) Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine\/threonine kinases PI3K\/Akt. Proc Natl Acad Sci USA 109:273","journal-title":"Proc Natl Acad Sci USA"},{"key":"444_CR96","doi-asserted-by":"crossref","first-page":"10186","DOI":"10.1074\/jbc.M117.796631","volume":"293","author":"H Tsukamoto","year":"2018","unstructured":"Tsukamoto H, Takeuchi S, Kubota K, Kobayashi Y, Kozakai S, Ukai I, Shichiku A, Okubo M, Numasaki M, Kanemitsu Y et al (2018) Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1-IKK\u03f5-IRF3 axis activation. J Biol Chem 293:10186\u201310201","journal-title":"J Biol Chem"},{"key":"444_CR97","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110755","volume":"39","author":"SO Vasudevan","year":"2022","unstructured":"Vasudevan SO, Russo AJ, Kumari P, Vanaja SK, Rathinam VA (2022) A TLR4-independent critical role for CD14 in intracellular LPS sensing. Cell Rep 39:110755","journal-title":"Cell Rep"},{"key":"444_CR98","doi-asserted-by":"crossref","first-page":"e60078","DOI":"10.1371\/journal.pone.0060078","volume":"8","author":"S Watanabe","year":"2013","unstructured":"Watanabe S, Kumazawa Y, Inoue J (2013) Liposomal lipopolysaccharide initiates TRIF-dependent signaling pathway independent of CD14. PLoS ONE 8:e60078","journal-title":"PLoS ONE"},{"key":"444_CR99","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1126\/science.1698311","volume":"249","author":"SD Wright","year":"1990","unstructured":"Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431","journal-title":"Science"},{"key":"444_CR100","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1087262","volume":"301","author":"M Yamamoto","year":"2003","unstructured":"Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K et al (2003) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301:640\u2013643","journal-title":"Science"},{"key":"444_CR101","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.1158\/0008-5472.CAN-07-0568","volume":"67","author":"Y Yang","year":"2007","unstructured":"Yang Y, Kitagaki J, Dai RM, Tsai YC, Lorick KL, Ludwig RL, Pierre SA, Jensen JP, Davydov IV, Oberoi P et al (2007) Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics. Cancer Res 67:9472\u20139481","journal-title":"Cancer Res"},{"key":"444_CR102","doi-asserted-by":"crossref","first-page":"E690","DOI":"10.1073\/pnas.1115485109","volume":"109","author":"B Zakeri","year":"2012","unstructured":"Zakeri B, Fierer JO, Celik E, Chittock EC, Schwarz-Linek U, Moy VT, Howarth M (2012) Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin. Proc Natl Acad Sci USA 109:E690\u2013E697","journal-title":"Proc Natl Acad Sci USA"},{"key":"444_CR103","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cell.2011.09.051","volume":"147","author":"I Zanoni","year":"2011","unstructured":"Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R, Barton GM, Granucci F, Kagan JC (2011) CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 147:868\u2013880","journal-title":"Cell"},{"key":"444_CR104","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/ALN.0000000000000337","volume":"121","author":"M Zhang","year":"2014","unstructured":"Zhang M, Zou L, Feng Y, Chen YJ, Zhou Q, Ichinose F, Chao W (2014) Toll-like receptor 4 is essential to preserving cardiac function and survival in low-grade polymicrobial sepsis. Anesthesiology 121:1270\u20131280","journal-title":"Anesthesiology"},{"key":"444_CR105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/embr.201338025","volume":"15","author":"J Zinngrebe","year":"2014","unstructured":"Zinngrebe J, Montinaro A, Peltzer N, Walczak H (2014) Ubiquitin in the immune system. EMBO Rep 15:28\u201345","journal-title":"EMBO Rep"},{"key":"444_CR106","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1111\/febs.15584","volume":"288","author":"T Zou","year":"2021","unstructured":"Zou T, Zhang J (2021) Diverse and pivotal roles of neddylation in metabolism and immunity. FEBS J 288:3884\u20133912","journal-title":"FEBS J"}],"container-title":["EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-025-00444-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44319-025-00444-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-025-00444-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:43:35Z","timestamp":1786985015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44319-025-00444-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":106,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,5,27]]}},"alternative-id":["444"],"URL":"https:\/\/doi.org\/10.1038\/s44319-025-00444-2","relation":{},"ISSN":["1469-221X","1469-3178"],"issn-type":[{"value":"1469-221X","type":"print"},{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"10 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"13"}}